Most people assume that when a drug patent expires, cheaper generics automatically become available. But behind the scenes, pharmaceutical companies use legal loopholes, secondary patents, and lawsuits to delay competition for years—sometimes decades.
One of the biggest weapons in this fight is Paragraph IV, a process that allows generic manufacturers to challenge patents. When they win, drug prices can drop by 80% or more, but big pharma doesn’t give up without a fight. The case of Lipitor, one of the best-selling drugs in history, shows just how far companies will go to protect their profits.
Who really benefits from this system? And why do patients keep paying the price? Read here: https://www.linkedin.com/pulse/battle-generics-how-paragraph-iv-reshapes-industry-i-pliner-iwjee/ What do you think? Coincidence, or just how the system is designed?
Posted by Foreign-Ira